Simba Gill
CIK: 0001180763
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 24, 2026FHTX
Foghorn Therapeutics Inc.
Award(A)DirectStock Options (Right to buy)
28K shares at avg. $4.08- - Feb 3, 2026SER
Serina Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
92K shares- - Jun 17, 2025FHTX
Foghorn Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
25K shares at avg. $4.79-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 24, 2026 |  FHTX Foghorn Therapeutics Inc. | Award(A) Stock Options (Right to buy) | 28,000 | $4.08 | - | Direct |
| Feb 3, 2026 |  SER Serina Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 92,000 | - | - | Direct |
| Jun 17, 2025 | FHTX Foghorn Therapeutics Inc. | Award(A) Stock Option (right to buy) | 25,000 | $4.79 | - | Direct |
1-3 of 3 transactions
About GILL SIMBA
GILL SIMBA (SEC CIK 0001180763) files insider reports with the SEC as Director of Foghorn Therapeutics Inc. (FHTX) and Director of Serina Therapeutics, Inc. (SER).
Signal8 holds 3 ownership filings by GILL SIMBA, all Form 4s, filed between Jun 17, 2025 and Jun 25, 2026. Those filings report 3 transactions, from Jun 17, 2025 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on GILL SIMBA's filings is in WATERTOWN, MA.
Recent filings by GILL SIMBA
Other insiders filing for Foghorn Therapeutics Inc. (FHTX)
- BVF PARTNERS L P/IL, 10% Owner
- Lynch Thomas J. Jr., Director
- Duty Stuart, Director
- Biller Scott, Director
- Gallagher Neil, Director
- Mendelsohn Michael, Director